139 related articles for article (PubMed ID: 12122014)
1. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H
J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014
[TBL] [Abstract][Full Text] [Related]
2. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
[TBL] [Abstract][Full Text] [Related]
3. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells.
Zrihan-Licht S; Lim J; Keydar I; Sliwkowski MX; Groopman JE; Avraham H
J Biol Chem; 1997 Jan; 272(3):1856-63. PubMed ID: 8999872
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of Csk and CHK kinases in breast cancer cells.
Bougeret C; Jiang S; Keydar I; Avraham H
J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575
[TBL] [Abstract][Full Text] [Related]
5. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
6. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
Ayrapetov MK; Lee S; Sun G
Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
Zagozdzon R; Bougeret C; Fu Y; Avraham HK
Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
[TBL] [Abstract][Full Text] [Related]
9. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
10. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.
Mikkola ET; Bergman M
FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282
[TBL] [Abstract][Full Text] [Related]
11. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
Grgurevich S; Mikhael A; McVicar DW
Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
[TBL] [Abstract][Full Text] [Related]
12. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.
Neet K; Hunter T
Mol Cell Biol; 1995 Sep; 15(9):4908-20. PubMed ID: 7544435
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.
Hirao A; Huang XL; Suda T; Yamaguchi N
J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
Okada M; Howell BW; Broome MA; Cooper JA
J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
[TBL] [Abstract][Full Text] [Related]
15. Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.
Price DJ; Rivnay B; Fu Y; Jiang S; Avraham S; Avraham H
J Biol Chem; 1997 Feb; 272(9):5915-20. PubMed ID: 9038210
[TBL] [Abstract][Full Text] [Related]
16. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
17. The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells.
Yamashita H; Avraham S; Jiang S; Dikic I; Avraham H
J Biol Chem; 1999 May; 274(21):15059-65. PubMed ID: 10329710
[TBL] [Abstract][Full Text] [Related]
18. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
[TBL] [Abstract][Full Text] [Related]
19. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
Mikkola ET; Gahmberg CG
J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
